Galapagos loses partner on inflammatory bowel drug
December 16, 2014 at 02:21 AM EST
BRUSSELS, Dec 16 (Reuters) - Belgian biotech group Galapagos said on Tuesday that its research partner Janssen Pharmaceutica, a unit of Johnson & Johnson, had pulled out of a programme to develop a new drug to treat bowel disease.
